Ivin 1 mg Injection
$1.19
$0.93
Ivin 1 mg Injection is a potent chemotherapy agent classified within the Vinca alkaloid family, primarily utilized in the treatment of various cancers, including lymphomas and solid tumors. This medication operates by inhibiting the proliferation of cancer cells, effectively disrupting their ability to divide and grow. It is crucial for patients to be aware of potential side effects, which may include nausea, hair loss, and increased susceptibility to infections, necessitating regular monitoring during treatment. Additionally, Ivin may lead to neurological effects, so prompt communication with healthcare providers about any unusual symptoms is essential. As with any chemotherapy regimen, a thorough discussion with your oncologist regarding the benefits and risks of Ivin 1 mg Injection is imperative for informed decision-making. By understanding how this medication works and adhering to prescribed protocols, patients can play an active role in their cancer management journey. Always ensure you follow the medical advice provided by your healthcare professional for the best outcomes.
Quantity
Active Pharmaceutical Ingredient
Uses
• Ivin 1 mg injection is utilized in the treatment of various types of cancers, including brain tumors. This medication helps to inhibit the growth of cancerous cells, making it an essential component in the management of such conditions. Patients receiving Ivin 1 mg injection may experience improved outcomes as part of a comprehensive cancer treatment plan. It is typically administered in a clinical setting under the supervision of healthcare professionals.
• In the realm of gynecological cancers, Ivin 1 mg injection is effective for treating cervical cancer. The injection works by targeting and slowing down the progression of cancer cells, providing patients with a potential extension of life and improved quality of life. This medication is often integrated into a multi-modal approach that may include surgery and radiation therapy. The use of Ivin 1 mg injection can be a vital part of a tailored treatment strategy for cervical cancer.
• Ivin 1 mg injection is also indicated for the management of colorectal cancer. By utilizing this medication, healthcare providers aim to reduce tumor size and mitigate the spread of cancer. The injection may be part of a combination therapy that enhances the overall effectiveness of treatment. Patients can expect to be monitored closely for their response to Ivin 1 mg injection during their cancer care journey.
• Additionally, Ivin 1 mg injection is beneficial in treating various sarcomas, such as Ewing's sarcoma and soft tissue sarcomas. This medication assists in controlling the proliferation of sarcoma cells, which is crucial for improving patient outcomes. Oncologists may recommend Ivin 1 mg injection based on individual patient needs and tumor characteristics. Its role in combination therapy can significantly contribute to a more effective cancer treatment regimen.
Benefits
Ivin 1 mg Injection is a chemotherapy drug. It is primarily used to treat various types of cancer. It is commonly used to treat acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML), especially when combined with other chemotherapeutic drugs. Its main function is to reduce the presence of leukaemia cells, both in the bone marrow and in the bloodstream. It is also used to treat Hodgkin and non-Hodgkin lymphomas and other lymphoproliferative disorders. It helps to shrink lymphoma tumours. It slows down their growth. It is also used to treat solid cancers such as neuroblastoma, Wilms tumour, rhabdomyosarcoma and Ewing sarcoma. It effectively reduces the size of these tumours. This makes them easier to remove surgically. In children, Ivin Injection can be used to treat certain brain tumours, including medulloblastoma and ependymoma. It has the potential to help control how the tumour grows and to relieve associated symptoms. In addition, Ivin 1 mg Injection can be used to treat cancer-related pain. By shrinking tumours that are pressing on nerves or causing discomfort, Ivin 1 mg Injection can provide pain relief for certain patients. However, it is important to note that while Ivin 1 mg may offer significant benefits in the treatment of cancer, it may also have potential side effects. For this reason, close monitoring by a team of healthcare professionals is crucial. Common side effects include peripheral neuropathy (tingling or numbness in the extremities), constipation, hair loss and low blood cell count. Patients who are receiving Ivin 1 mg Injection should be monitored closely for these side effects, and their treatment may be adjusted accordingly to ensure that these problems are managed effectively. It is important to emphasise that Ivin 1 mg should only be used under the supervision of a qualified oncologist who can assess the risks and benefits specific to each patient.
Side Effects
Like all medicines, this Ivin 1 mg Injection can cause side effects, although not everybody gets them. Your doctor will discuss these with you and explain the risks and benefits of your treatment.
Most Common Side Effects
• Hair loss
• Headache
• Constipation
• Loss of appetite
• Numbness of feet and arms
• Stomach pain
Common Side Effects
• Severe allergic reaction
• Chest pain
• Breathing problem
• Sepsis
How To Use
Please ensure that Ivin 1 mg Injection is being administered by a doctor or nurse and do not discontinue use without the advice of your health care professional.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Ivin 1 mg. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Patients with kidney disease should closely monitor kidney function while taking Ivin 1 mg and report any unusual symptoms or changes in kidney function to their physician. The dose of Ivin 1 mg should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not known whether Ivin 1 mg Injection is excreted in human milk. Because many drugs, including other anthracyclines, are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Ivin 1 mg Injection, lactating women should be advised not to breastfeed during treatment with Ivin 1 mg and for at least 7 days after last dose.
• Liver: Ivin 1 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Ivin 1 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Ivin 1 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Ivin 1 mg Injection may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Ivin 1 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Ivin 1 mg Injection may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Ivin 1 mg.